HEC

Serial Number 79227076
Registration 5736027
706

Registration Progress

Application Filed
Nov 27, 2017
Under Examination
Approved for Publication
Jan 23, 2019
Published for Opposition
Feb 12, 2019
Registered
Apr 30, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-30) (Grace Period Filing)
Due: Oct 30, 2025 Grace Period - 51 days
Original deadline was Apr 30, 2025 (overdue)

Trademark Image

HEC

Basic Information

Serial Number
79227076
Registration Number
5736027
Filing Date
November 27, 2017
Registration Date
April 30, 2019
Published for Opposition
February 12, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
706
Status Date
Jul 21, 2025
Registration
Registered
Classes
005

Rights Holder

Yichang HEC Changjiang Pharmaceutical Co., Ltd.

99
Address
No. 38, Binjiang Road,
Yidu City,; Yichang; 443300 Hubei Province
CN

Ownership History

Yichang HEC Changjiang Pharmaceutical Co., Ltd.

Original Applicant
99
CN

Yichang HEC Changjiang Pharmaceutical Co., Ltd.

Owner at Publication
99
CN

Yichang HEC Changjiang Pharmaceutical Co., Ltd.

Original Registrant
99
CN

Legal Representation

Attorney
Alexander Ruzzier

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-30)
Due Date
April 30, 2025
Grace Period Ends
October 30, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Jul 21, 2025 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Jul 21, 2025 71AG O REGISTERED-SEC.71 ACCEPTED Loading...
Jul 15, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 21, 2025 ES71 I TEAS SECTION 71 RECEIVED Loading...
Apr 30, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Oct 11, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 16, 2019 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Aug 16, 2019 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Jul 30, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 30, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 18, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 18, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 12, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 8, 2019 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 23, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 23, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 23, 2019 NPUB O NOTICE OF PUBLICATION Loading...
Jan 8, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 19, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 19, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 17, 2018 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Dec 13, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 13, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 11, 2018 NREV O NOTICE OF REVIVAL - MAILED Loading...
Dec 10, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 10, 2018 PETG O PETITION TO REVIVE-GRANTED Loading...
Dec 10, 2018 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Oct 11, 2018 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Oct 11, 2018 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 30, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 15, 2018 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 15, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Mar 10, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 9, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 8, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 3, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 27, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 15, 2018 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Medicines for human purposes for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders, cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; Medicines for human purposes, namely, anti-infectives and antivirals; Pharmaceutical preparations for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Pharmaceutical preparations, namely, anti-infectives and antivirals; Pharmaceutical preparations for the treatment of cough, cold and flu symptoms; adjuvants for medical purposes; Bulk drug in the nature of a pharmaceutical preparation for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Bulk drug in the nature of a pharmaceutical preparation, namely, anti-infectives and antivirals; Bulk drug in the nature of a pharmaceutical preparation for the treatment of hypertension, alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; Chinese patent medicines, for use in the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Chinese patent medicines, namely, anti-infectives and antivirals; Chinese patent medicines, for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, anti-inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; Biochemical medicines for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Biochemical medicines, namely, anti-infectives and antivirals; Biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; Medicinal infusions for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Medicinal infusions, namely, anti-infectives and antivirals; Medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, obesity, obesity associated with type 2 diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; diagnostic preparations for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; contact lens cleaning preparations; Nutritive substances for microorganisms for medical purposes; disinfectants; food for babies; infant milk powder; depuratives for the body; Veterinary preparations for horses, dogs, and cats for the prevention and treatment of pain, illness, and fatigue; Medicine health bag being medicinal herbs for general health and well-being contained in a small bag; Decoctions for pharmaceutical purposes for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Decoctions for pharmaceutical purposes, namely, anti-infectives and antivirals; Decoctions for pharmaceutical purposes for treatment of immune disorders; Drugs for medical purposes, namely, for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, ocular, reproductive, circulatory, digestive, ear, blood, psychiatric, behavioral, nervous, and immune system related diseases and disorders; Drugs for medical purposes, namely, anti-infectives and antivirals; Medical hemostatic paste; medicinal herbs; Transdermal patches for use in the temporary relief of headache and muscle pain; medicinal tea; Allergy capsules; soporifics; Biological preparations for medical purposes, namely, for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Biological preparations for medical purposes, namely, anti-infectives and antivirals; medical preparations for slimming purposes; medicinal wine; poultices; Medicine cases, portable, filled, namely, first aid kits; Medicinal oil; Liquid medicines for the treatment of digestive system disorders, cardiovascular disorders, nervous system disorders, metabolic system disorders and dermal diseases; Liquid medicines, namely, anti-infectives and antivirals; Liquid medicines for treating colds; Medicines for veterinary purposes for treating and preventing infections caused by bacteria or parasites in companion and food producing animals; surgical dressings; solutions for contact lenses

Additional Information

Design Mark
The mark consists of a shaded circle with a curved line dividing the circle at the bottom. Above the curved line is the design of caterpillar fungus. Below the curved line are the stylized letters "HEC".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005